Aspirin and Plavix Following Coronary Artery Bypass Grafting

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Coronary Graft Patency

In brief

The design of the study will be randomized, double blind trial, which will examine the effects of addition of clopidogrel to current guideline recommended background therapy on lowering the incidence of graft stenosis after coronary artery bypass grafting compared to placebo.

Key facts

Study ID

NCT01158703

Run by

Ahmad Slim

People needed

20

Starts

2010-07-01

Expected to finish

2014-12-01

Last updated by the study team

2015-05-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients undergoing coronary artery bypass grafting, with or without cardiopulmonary bypass
• Age ≥ 18

You may not qualify if…

• Left ventricle ejection fraction <30%
• Emergency surgery
• Valve surgery
• Redo CABG
• Postoperative cardiogenic shock for more than 48 hours
• Postoperative bleeding or cardiac tamponade
• More than 24 hours postoperative intubation course
• Requirement of postoperative anticoagulation
• Serum creatinine >1.4
• Contraindication to use of postoperative coronary CT scan
• Allergy or contraindication to aspirin or clopidogrel
• Inability to provide informed consent
• Pregnant or breast feeding females

Where it is running

• Brooke Army Medical Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.